- Home
- AUROW vs VCEL Comparison
AUROW vs VCEL Comparison
Compare AUROW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUROW
- VCEL
- Stock Information
- Founded
- AUROW 2017
- VCEL 1989
- Country
- AUROW United States
- VCEL United States
- Employees
- AUROW 1800
- VCEL N/A
- Industry
- AUROW EDP Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUROW Technology
- VCEL Health Care
- Exchange
- AUROW Nasdaq
- VCEL Nasdaq
- Market Cap
- AUROW N/A
- VCEL 2.1B
- IPO Year
- AUROW N/A
- VCEL 1997
- Fundamental
- Price
- AUROW N/A
- VCEL $40.15
- Analyst Decision
- AUROW
- VCEL Strong Buy
- Analyst Count
- AUROW 0
- VCEL 8
- Target Price
- AUROW N/A
- VCEL $62.00
- AVG Volume (30 Days)
- AUROW 137.0K
- VCEL 430.8K
- Earning Date
- AUROW 04-30-2025
- VCEL 07-31-2025
- Dividend Yield
- AUROW N/A
- VCEL N/A
- EPS Growth
- AUROW N/A
- VCEL 521.85
- EPS
- AUROW N/A
- VCEL 0.05
- Revenue
- AUROW N/A
- VCEL $238,541,000.00
- Revenue This Year
- AUROW N/A
- VCEL $23.03
- Revenue Next Year
- AUROW N/A
- VCEL $24.52
- P/E Ratio
- AUROW N/A
- VCEL $705.61
- Revenue Growth
- AUROW N/A
- VCEL 14.80
- 52 Week Low
- AUROW $2.09
- VCEL $37.39
- 52 Week High
- AUROW $3.00
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- AUROW N/A
- VCEL 44.33
- Support Level
- AUROW N/A
- VCEL $40.53
- Resistance Level
- AUROW N/A
- VCEL $43.57
- Average True Range (ATR)
- AUROW 0.00
- VCEL 1.62
- MACD
- AUROW 0.00
- VCEL -0.16
- Stochastic Oscillator
- AUROW 0.00
- VCEL 28.65
About AUROW Aurora Innovation Inc. Warrant
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.